2018 American Transplant Congress
Impact of Providing Care Locally Compared to at a Transplant Center for Pre-And Posttransplant Liver Patients
There is a potential to improve patient satisfaction as well as access to liver transplantation (LT). AIM: This study evaluated outcomes of LT recipients whose…2018 American Transplant Congress
Outcomes after Kidney Transplant (KTx) from Deceased Donors (DD) Aged ≥ 70
Background:There has been an increase in DD aged 70 or greater and transplant centers are reluctant to accept these organs. The aim of this study…2018 American Transplant Congress
Multivariate Cox Proportional Hazards Model for Estimating Long-Term Risk of Aging Kidney Transplant Recipients
Henry Ford Transplant Institute, Detroit, MI.
Purpose: The growing number of elderly kidney transplant recipients (KTR) presents an opportunity to analyze and predict long-term outcomes and risk in this aging population.Methods:…2018 American Transplant Congress
Outcomes Analysis of Liver Transplantation Combined with Neoadjuvant Therapy in Patients with Unresectable Locally-Advanced Cholangiocarcinoma
Objective: Liver transplantation (LT) combined with neoadjuvant chemoradiation (NCR) in well-selected patients with unresectable cholangiocarcinoma (CCA) achieves excellent long-term recurrence-free survival. Current criteria for NCR-LT…2018 American Transplant Congress
Clostridium Difficile Infection after Liver Transplant is Associated with Poor Long-Term Survival
Division of Organ Transplantation, Umass Memorial Medical Center, Worcester, MA.
Background: Clostridium Difficile infection (CDI) is a growing problem in hospitalized patients and occurs in liver transplant recipients at a higher rate than non-transplant patients.…2018 American Transplant Congress
Frailty is Predictive of Early Post-Transplant Infection in Older Renal Transplant Recipients
Background: Frailty is predictive of postoperative morbidity, including infections in older surgical patients. It is not known if frailty is associated with post-operative infections in…2018 American Transplant Congress
C1q-Binding Donor-Specific Anti-HLA Antibodies for Clinical Decision Making in Kidney Recipients with Antibody-Mediated Rejection Receiving Standard of Care Treatment
One of the major issues in the clinical management of kidney recipients with ABMR is the lack of early and reliable markers that surrogate long-term…2018 American Transplant Congress
Liver Transplantation in Patients with Spontaneous Spleno-Renal Shunt
Aim: Our aim was to describe the outcomes of liver transplantation (LT) in patients with spontaneous spleno-renal shunt (SSRS) and to define the adequate portal…2018 American Transplant Congress
Living Donor Renal Transplantation in Adult Renal Transplant Recipients Varies Markedly across UNOS Networks
Background: Outcome after living donor kidney transplantation (LD) is significantly better than after deceased donor transplantation (DD). Disparities in access to living donor renal transplantation…2018 American Transplant Congress
What Threshold MFI is the Luminex 1:8 Dilution the Poor Man's C1q for Patients Awaiting Heart Transplant?
Cedars Sinai Medical Center, Los Angeles.
Purpose: Heart transplant candidates are evaluated for anti-HLA antibodies by Luminex single-antigen bead testing to avoid donors that may harbor antigens that these antibodies are…
American Transplant Congress abstracts